Home/Hedge Fund Intelligence/Mirum Pharmaceuticals, Inc.
Nasdaq: MIRMStockForm 13F30 Jun 2026

Hedge funds that hold Mirum Pharmaceuticals, Inc. Nasdaq: MIRM

CUSIP 604749101 · who reports it, how much, and how much it matters to them

31 of the 720 hedge fund managers we track reported shares of Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) on Form 13F for 30 June 2026. Between them they reported USD 719m. The largest position belongs to Polar Capital LLP, at USD 99m. The manager with the most riding on it is Boone Capital Management, where it is 11.4% of the reported book.

Managers reporting it31of 720 we track
Value they reportUSD 719mshares only, 30 Jun 2026
Funds they run297with a file on PPLI.com
Largest positionUSD 99mPolar Capital LLP
Typical weight0.2%median share of a manager's book
Heaviest weight11.4%Boone Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

31 managers, USD 719m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Mirum Pharmaceuticals, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Polar Capital LLP26 funds on PPLI.comUSD 99m0.2%
2Rock Springs Capital Management2 funds on PPLI.comUSD 93m4.6%
3Two Sigma Investments35 funds on PPLI.comUSD 81m0.1%
4Balyasny Asset Management25 funds on PPLI.comUSD 57m0.1%
5Baker Bros. Advisors2 funds on PPLI.comUSD 52m0.3%
6Renaissance Technologies13 funds on PPLI.comUSD 52m0.1%
7Boone Capital Management1 fund on PPLI.comUSD 49m11.4%
8Adage Capital Management1 fund on PPLI.comUSD 41m0.1%
9Palo Alto Investors6 funds on PPLI.comUSD 41m5.6%
10Octagon Capital Advisors1 fund on PPLI.comUSD 40m3.6%
11Ra Capital Management1 fund on PPLI.comUSD 37m0.3%
12Perceptive Advisors6 funds on PPLI.comUSD 14m0.2%
13Capricorn Fund Managers8 funds on PPLI.comUSD 12m0.9%
14Millennium Management6 funds on PPLI.comUSD 11m0.0%
15Voleon Capital Management13 funds on PPLI.comUSD 9.7m0.2%
16Aquatic Capital Management3 funds on PPLI.comUSD 4.3m0.1%
17Neo Ivy Capital Management1 fund on PPLI.comUSD 4.2m1.0%
18PFM Health Sciences3 funds on PPLI.comUSD 3.7m0.3%
19Resolute Capital Asset Partners1 fund on PPLI.comUSD 3.5m1.5%
20D. E. Shaw & Co.15 funds on PPLI.comUSD 3.3m0.0%
21Sofinnova Investments1 fund on PPLI.comUSD 3.2m0.2%
22Jain Global1 fund on PPLI.comUSD 2.5m0.0%
23HighVista Strategies27 funds on PPLI.comUSD 1.7m0.4%
24Mangrove Partners Im1 fund on PPLI.comUSD 1.2m0.1%
25Engineers Gate Manager1 fund on PPLI.comUSD 953,0000.0%
26Entrypoint Capital1 fund on PPLI.comUSD 603,0000.1%
27Persistent Asset Partners10 funds on PPLI.comUSD 516,0000.2%
28Squarepoint Ops7 funds on PPLI.comUSD 339,0000.0%
29Prelude Capital Management9 funds on PPLI.comUSD 272,0000.0%
30CIBC Asset Management69 funds on PPLI.comUSD 218,0000.0%
31The Quarry1 fund on PPLI.comUSD 1,8730.0%
Next: where it matters most
Where it matters most

For Boone Capital Management it is 11.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Boone Capital ManagementUSD 49m11.4%
2Palo Alto InvestorsUSD 41m5.6%
3Rock Springs Capital ManagementUSD 93m4.6%
4Octagon Capital AdvisorsUSD 40m3.6%
5Resolute Capital Asset PartnersUSD 3.5m1.5%
6Neo Ivy Capital ManagementUSD 4.2m1.0%
7Capricorn Fund ManagersUSD 12m0.9%
8HighVista StrategiesUSD 1.7m0.4%
9Ra Capital ManagementUSD 37m0.3%
10PFM Health SciencesUSD 3.7m0.3%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Mirum Pharmaceuticals, Inc.

What is the ticker symbol of Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. trades under the symbol MIRM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 604749101.

Which hedge funds own Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM)?

31 of the 720 hedge fund managers PPLI.com tracks reported Mirum Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Polar Capital LLP (USD 99m), Rock Springs Capital Management (USD 93m), Two Sigma Investments (USD 81m), Balyasny Asset Management (USD 57m) and Baker Bros. Advisors (USD 52m).

How many hedge funds hold Mirum Pharmaceuticals, Inc.?

31 managers in our coverage reported it, and between them they run 297 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Mirum Pharmaceuticals, Inc.?

Boone Capital Management, where the position was 11.4% of the reported 13F book at 30 June 2026.

Does this show who is short Mirum Pharmaceuticals, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Mirum Pharmaceuticals, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.